The most common genetic killer of infants, a disease known as spinal muscular atrophy, is caused by mutations in a single gene. The human genome contains its own backup system — near-identical copies of the defective gene — yet these secondary sequences rarely get used correctly.
As Elie Dolgin finds out, drug companies hope to change that, with the first wave of targeted therapies that reboot the body's backup system now entering clinical trials.
In response to cellular stress, proteins become ensnared in chemical traffic jams, creating a kind of widespread sluggishness scientists call “proteolethargy.”
USEFUL LINKS
CONTACT
elie@eliedolgin.com
Contact Us
Thank you for contacting us. We will get back to you as soon as possible.
Oops, there was an error sending your message. Please try again later.